Amikacin liposome Interactions
There are 178 drugs known to interact with amikacin liposome, along with 4 disease interactions. Of the total drug interactions, 64 are major, 113 are moderate, and 1 is minor.
- View all 178 medications that may interact with amikacin liposome
- View amikacin liposome disease interactions (4)
Most frequently checked interactions
View interaction reports for amikacin liposome and the medicines listed below.
- Activated Charcoal (charcoal)
- Adrenalin (epinephrine)
- Albenza (albendazole)
- Albumarc (albumin human)
- Aloprim (allopurinol)
- Amoxil (amoxicillin)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Azithromycin Dose Pack (azithromycin)
- B Complex 100 (multivitamin)
- Calcium 600 D (calcium / vitamin d)
- Calcium 600+D Plus Minerals (multivitamin with minerals)
- Caltrate 600+D (calcium / vitamin d)
- Cyanoject (cyanocobalamin)
- Diltiazem Hydrochloride SR (diltiazem)
- Folinic-Plus (multivitamin)
- Hyosyne (hyoscyamine)
- Insulin Purified NPH Pork (insulin isophane)
- Ipratropium Inhalation Solution (ipratropium)
- Iron Gluconate (ferrous gluconate)
- Iron Sulfate (ferrous sulfate)
- Iron-150 (multivitamin with iron)
- Lipidil Micro (fenofibrate)
- Lithium Carbonate ER (lithium)
- Meticorten (prednisone)
- Metoprolol Tartrate (metoprolol)
- MetroGel (metronidazole topical)
- Morphine Sulfate ER (morphine)
- Mycamine (micafungin)
- Mycostatin (nystatin)
- Paracetamol (acetaminophen)
Amikacin liposome disease interactions
There are 4 disease interactions with amikacin liposome which include:
More about amikacin liposome
- amikacin liposome consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: aminoglycosides
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.